Dubai Investments

Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed seven strategic Memorandums of Understanding (MoUs) with leading partners to strengthen its capabilities across research and development, manufacturing optimisation, financing and sustainable operations. The collaborations are structured across three strategic clusters — innovation and product development, manufacturing, efficiency and sustainability, market access, financing and expansion — supporting Globalpharma’s efforts to strengthen capabilities across the pharmaceutical value chain. The MoUs establish collaboration frameworks with partners aligned to these clusters, including ZIM Laboratories FZE ...